作为混合单胺转运体连接体的prolintane类似物:结构决定因素和物种差异
Nina Kastner1, Mohammad N Islam1, Michael Dybek2
1Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria.
The Journal of biological chemistry
|November 6, 2025
概括
新的prolintane类似物显示强烈抑制多巴胺和北上腺素载体. 环的修改揭示了人类血清素载体的混合活性,表明滥用潜力和物种特异性影响的改变.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 由于滥用担忧,Prolintane是一种兴奋剂,因此被停止使用.
- 了解结构-活动关系对于开发更安全的类似物至关重要.
研究的目的:
- 合成和表征新的和甲基环替代的前列.
- 研究它们在单胺转运体中的结构-活性关系.
- 评估潜在的滥用责任和物种差异.
主要方法:
- 修改的一曼尼希巴比耶反应用于合成.
- 在HEK293细胞和老鼠突触体中进行射线追踪器流量测试.
- 测量单胺转运体抑制和基质活性.
主要成果:
- 普罗林坦的类似物有力抑制多巴胺转运体 (DAT) 和北上腺素转运体 (NET).
- 甲基和替代物调节了DAT/SERT比率,可能减少滥用责任.
- 化合物作为人类血清素载体 (hSERT) 的基质,诱导血清素释放,与大鼠模型不同.
结论:
- 普罗林坦类似物在人类单胺转运器上表现出混合药理学.
- 环的修改显著改变了普罗林坦与DAT,NET和hSERT的相互作用.
- 在hSERT活动中的物种差异凸显了对治疗效果和不良影响的进一步调查的需要.
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Nonlinear Pharmacokinetics: Role of Transporters
266
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
266
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
863
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
863
Antidepressant Drugs: MAOIs and Other Agents
784
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
784


